Horsham, Pennsylvania, United States Janssen Biotech is the famous Corporate Investor, which was founded in 1979. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Horsham.
The standard case for the fund is to invest in rounds with 1 partaker.
The top activity for fund was in 2013. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.
Among the most successful fund investment fields, there are Biotechnology, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Amphivena Therapeutics Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund.
| Fund Name | Location |
| Barclays Accelerator Powered by Techstars - Cape Town | Gauteng, NA - South Africa, South Africa |
| Finlombarda Gestioni SGR | Italy, Lombardy, Milan |
| Hive Technologies | - |
| HNI's | - |
| Next Capital | Beijing, Beijing, China |
| Shanghai Qinda Investment Holding Group | China, Shanghai |
| Signal Sciences | California, Culver City, United States |
| THSP Zhuhai Park | China, Guangdong, Zhuhai |
| Upstage Ventures | Ardsley, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Amphivena Therapeutics | $14M | 15 Jul 2013 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Amphivena Therapeutics | $14M | 15 Jul 2013 | South San Francisco, California, United States |
